NEW YORK, March 15 – Nanogen said Thursday it had shipped a new system designed for targeted gene expression applications for beta testing at two undisclosed US institutions and one in Europe.

Nanogen plans to use the results of the tests to develop new applications for detecting gene expression. Currently the company’s NanoChip system is primarily used do detect and analyze SNPs, short tandem repeats, and mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.